{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:54:42Z","timestamp":1770825282279,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,5,29]],"date-time":"2010-05-29T00:00:00Z","timestamp":1275091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10620-010-1257-7","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T11:20:56Z","timestamp":1275045656000},"page":"2373-2380","source":"Crossref","is-referenced-by-count":69,"title":["Nucleoside Analogue Can Improve the Long-Term Prognosis of Patients with Hepatitis B Virus Infection-Associated Acute on Chronic Liver Failure"],"prefix":"10.1007","volume":"55","author":[{"given":"Yao-Li","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Qin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Zhong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,29]]},"reference":[{"key":"1257_CR1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","volume":"337","author":"WM Lee","year":"1997","unstructured":"Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733\u20131745.","journal-title":"N Engl J Med"},{"key":"1257_CR2","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1056\/NEJMcp041507","volume":"351","author":"GA Poland","year":"2004","unstructured":"Poland GA, Jacobson RM. Clinical practice: Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med. 2004;351:2832\u20132838.","journal-title":"N Engl J Med"},{"key":"1257_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin SK, Kumar A, Almeida J, et al. Acute on chronic liver failure (ACLF): Consensus recommendations of the Asian pacific association for the study of liver failure (APASL). Hepatol Int. 2009;3:269\u2013282.","journal-title":"Hepatol Int"},{"key":"1257_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8278(88)80475-6","volume":"7","author":"C Vickers","year":"1988","unstructured":"Vickers C, Neuberger J, Buckels McMaster P, Elias E. Transplantation of liver in adults and children with fulminant liver failure. J Hepatol. 1988;7:143\u2013150.","journal-title":"J Hepatol"},{"key":"1257_CR5","first-page":"152","volume":"70","author":"S Uemoto","year":"2000","unstructured":"Uemoto S, Inomata Y, Sakurai T, et al. Living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;70:152\u2013157.","journal-title":"Transplantation"},{"key":"1257_CR6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1526-0968.2004.00149.x","volume":"8","author":"T Abe","year":"2004","unstructured":"Abe T, Kobata H, Hanba Y, et al. Study of plasm exchange for LF: Beneficial and harmful effects. Ther Apher Dial. 2004;8:180\u2013184.","journal-title":"Ther Apher Dial"},{"key":"1257_CR7","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2000.02268.x","volume":"95","author":"K Ryo","year":"2000","unstructured":"Ryo K, Kamogawa Y, Ikeda I, et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol. 2000;95:2047\u20132055.","journal-title":"Am J Gastroenterol"},{"key":"1257_CR8","first-page":"748","volume":"91","author":"JW Fang","year":"1996","unstructured":"Fang JW, Shen WW, Meager A, et al. Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. Am J Gastroenterol. 1996;91:748\u2013753.","journal-title":"Am J Gastroenterol"},{"key":"1257_CR9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0016-5085(84)90406-2","volume":"86","author":"GL Davies","year":"1984","unstructured":"Davies GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology. 1984;86:230\u2013235.","journal-title":"Gastroenterology"},{"issue":"5","key":"1257_CR10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00004836-199010000-00015","volume":"12","author":"S Gupta","year":"1990","unstructured":"Gupta S, Govindarajan S, Fong TL, Redeker AG. Spontaneous reactivation of chronic hepatitis B: Patterns and natural history. J Clin Gastroenterol. 1990;12(5):562\u2013568.","journal-title":"J Clin Gastroenterol"},{"issue":"3 Part 1","key":"1257_CR11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/hep.1840120320","volume":"12","author":"P Levy","year":"1990","unstructured":"Levy P, Marcellin P, Martinot-Peignoux M, et al. Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology. 1990;12(3 Part 1):570\u2013574.","journal-title":"Hepatology"},{"key":"1257_CR12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521\u20131531.","journal-title":"N Engl J Med"},{"key":"1257_CR13","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa042957","volume":"352","author":"SJ Hadziyannis","year":"2005","unstructured":"Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med. 2005;352:2673\u20132681.","journal-title":"N Engl J Med"},{"key":"1257_CR14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","volume":"354","author":"TT Chang","year":"2006","unstructured":"Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354:1001\u20131010.","journal-title":"N Engl J Med"},{"key":"1257_CR15","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1016\/S1590-8658(07)60017-6","volume":"39","author":"GB Gaeta","year":"2007","unstructured":"Gaeta GB, Stornaiuolo G. Therapy of chronic hepatitis B: Focus on telbivudine. Dig Liver Dis. 2007;39:S372\u2013S378.","journal-title":"Dig Liver Dis"},{"key":"1257_CR16","first-page":"410","volume":"14","author":"QF Sun","year":"2006","unstructured":"Sun QF, Lu Y, Xu DZ, et al. The impact of HBeAg positivity\/negativity and HBV-DNA loads on the prognosis of chronic severe hepatitis B. Zhonghua Gan Zang Bing Za Zhi. 2006;14:410\u2013413.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"1257_CR17","first-page":"120","volume":"21","author":"YZ Wu","year":"2007","unstructured":"Wu YZ, Zhao FL, Zhang CZ, et al. Factors related to the outcome of patients with chronic severe hepatitis B and effectiveness of antivirus therapy. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007;21:120\u2013122.","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"1257_CR18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1440-1746.2008.05484.x","volume":"23","author":"JW Yu","year":"2008","unstructured":"Yu JW, Sun LJ, Zhao YH, Li SC. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment. J Gastroenterol Hepatol. 2008;23:1242\u20131249.","journal-title":"J Gastroenterol Hepatol"},{"key":"1257_CR19","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1046\/j.1365-2036.2001.01107.x","volume":"15","author":"SWC Tsang","year":"2001","unstructured":"Tsang SWC, Chan HLY, Leung NWY, et al. Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection. Aliment Pharmacol Ther. 2001;15:1737\u20131744.","journal-title":"Aliment Pharmacol Ther"},{"key":"1257_CR20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1572-0241.2001.03559.x","volume":"96","author":"A Tsubota","year":"2001","unstructured":"Tsubota A, Arase Y, Saitoh S, et al. Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study. Am J Gastroenterol. 2001;96:557\u2013562.","journal-title":"Am J Gastroenterol"},{"key":"1257_CR21","first-page":"261","volume":"8","author":"J Chen","year":"2009","unstructured":"Chen J, Han JH, Liu C, et al. Short-term entecavir therapy of chronic severe hepatitis B. Hepatobiliary Pancreat Dis Int. 2009;8:261\u2013266.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1257_CR22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2893.2002.00385.x","volume":"9","author":"HLY Chan","year":"2002","unstructured":"Chan HLY, Tsang SWC, Hui Y, et al. The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice. J Viral Hepatol. 2002;9:424\u2013428.","journal-title":"J Viral Hepatol"},{"key":"1257_CR23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0168-8278(02)00419-1","volume":"38","author":"RN Chien","year":"2003","unstructured":"Chien RN, Lin CH, Liaw YF. The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B. J Hepatol. 2003;38:322\u2013327.","journal-title":"J Hepatol"},{"key":"1257_CR24","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864\u2013871.","journal-title":"Hepatology"},{"key":"1257_CR25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1053\/jhep.2000.7296","volume":"31","author":"CT Yeh","year":"2000","unstructured":"Yeh CT, Chien RN, Chu CM, Liaw YF. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology. 2000;31:1318\u20131326.","journal-title":"Hepatology"},{"key":"1257_CR26","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","volume":"48","author":"DJ Tenney","year":"2004","unstructured":"Tenney DJ, Levine SM, Rose RE, et al. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine. Antimicrob Agents Chemother. 2004;48:3498\u20133507.","journal-title":"Antimicrob Agents Chemother"},{"key":"1257_CR27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2008.03816.x","volume":"28","author":"JJ Sung","year":"2008","unstructured":"Sung JJ, Tsoi KK, Wong VW, Li KC, Chan HL. Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. Aliment Pharmacol Ther. 2008;28:1067\u20131077.","journal-title":"Aliment Pharmacol Ther"},{"key":"1257_CR28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jmv.10185","volume":"68","author":"HL Chan","year":"2002","unstructured":"Chan HL, Chui AK, Lau WY, et al. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. J Med Virol. 2002;68:182\u2013187.","journal-title":"J Med Virol"},{"key":"1257_CR29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jmv.21369","volume":"81","author":"JL Limquiaco","year":"2009","unstructured":"Limquiaco JL, Wong J, Wong VW, et al. Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: A seven-year follow-up study. J Med Virol. 2009;81:224\u2013229.","journal-title":"J Med Virol"},{"key":"1257_CR30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1440-1746.2004.03534.x","volume":"20","author":"A Tsubota","year":"2005","unstructured":"Tsubota A, Arase Y, Suzuki Y, et al. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol. 2005;20:426\u2013432.","journal-title":"J Gastroenterol Hepatol"},{"key":"1257_CR31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/jhep.2002.35532","volume":"36","author":"L Leifeld","year":"2002","unstructured":"Leifeld L, Cheng S, Ramakers J, et al. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology. 2002;36:1001\u20131008.","journal-title":"Hepatology"},{"key":"1257_CR32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000232940","volume":"28","author":"Q Liu","year":"2009","unstructured":"Liu Q. Role of cytokines in the pathophysiology of acute-on-chronic liver failure. Blood Purif. 2009;28:331\u2013341.","journal-title":"Blood Purif"},{"key":"1257_CR33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1440-1746.2009.05924.x","volume":"24","author":"VW Wong","year":"2009","unstructured":"Wong VW, Chan HL. Severe acute exacerbation of chronic hepatitis B: A unique presentation of a common disease. J Gastroenterol Hepatol. 2009;24:1179\u20131186.","journal-title":"J Gastroenterol Hepatol"},{"key":"1257_CR34","first-page":"607","volume":"17","author":"X Liu","year":"2009","unstructured":"Liu X, Hu J, Wang H. Analysis of prognosis factors for patients with acute-on-chronic liver failure. Zhonghua Gan Zang Bing Za Zhi. 2009;17:607\u2013610.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1257-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1257-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1257-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:42:58Z","timestamp":1559230978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1257-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,29]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1257-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,29]]}}}